Discussion Board

Most Discussed: ULTA BIG NVDA CVS MED Ken Fisher PGR Presidential Cycle, Political Parties and the Stock Market Guru Portfolios Latest Picks

Topic	Replies	Activity
What she bet most out of is Uipath (PATH) and Twillo ( TWLO). Article Comments Disruptive Dive: Decoding Catherine Wood's Bold Bets	0	Sep 26, 2023
Taking risks will blow my mind. Article Comments AMTD Digital: Behind the Hype, Risks Lurk for the Overvalued Stock	1	Sep 23, 2023
Appreciate the update and the clarification on yesterday's price drop Article Comments Tesla: Heading for a 3rd-Quarter Deliveries Miss	0	Sep 22, 2023
As a student, I've encountered my fair share of challenges in my studies. One of the most common issues I face is information overload. The vast amoun Article Comments Talladega College Partners with Kaplan to Offer Students Free Comprehensive Prep for Graduate-Level Admissions Exams and Professional Certifications	0	Sep 21, 2023
If you look at the filing, Mr. Elmasri purchased the 500K shares for $0.00 so in that light not exactly a good thing. Article Comments Insider Buying: CFO Saleem Elmasri Acquires 500,000 Shares of Bright Green Corp (BGXX)	0	Sep 18, 2023
Good summary of the book - quite difficult to practically implement as good quality companies / compounders are mostly always trading at high valuations and mostly slow growth low ROC companies at a discount Article Comments Why Seth Klarman Swears by the Margin of Safety	1	Sep 18, 2023
I suspect that something unique to SMCI is "breaking" your formula for GF value. Its number, and therefore the resulting conclusion, run contrary to s Article Comments Super Micro Computer (SMCI): A Deep Dive into its Overvalued Status	2	Sep 17, 2023
"Align Technology Inc has witnessed a surge of 0.02% over a period" .... Please stop those absurd AI articles.... Article Comments Unveiling the Investment Potential of Align Technology Inc (ALGN): A Comprehensive Analysis	0	Sep 16, 2023
Heading is misleading, definitely NOT a comprehensive analysis. Article Comments Is Illumina (ILMN) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap	0	Sep 15, 2023
This price of a share is very high. I know it does not matter - but buying 10 shares will take $40 K - a price of a nice car. Article Comments Booking Holdings: An Undervalued Travel Play	0	Sep 14, 2023
Good writing Article Comments DaVita Continues to Support Critical Health Care Needs	0	Sep 14, 2023
Interesting that Gurufocus is now allowing articles for Cannabis companies. Previously I was told that these articles were not allowed.Also notably th Article Comments What's Driving Tilray Brands Inc's Surprising 104% Stock Rally?	1	Sep 12, 2023
Thanks for highlighting Forward Air. The stock looks very interesting. Article Comments Executives Bought Shares at Forward Air and Fox	0	Sep 12, 2023
Berkshire Hatheway is terrible. Article Comments Warren Buffett's Berkshire Hathaway Makes Bold Move, Increases Bet on Financial Giant	1	Sep 12, 2023
consider whether resmed has benefitted from Phillip’s cpap recall and whether resmed will be negatively affected when phillips comes back into t Article Comments ResMed (RMD): An Uncovered Gem? Unveiling Its True Value	0	Sep 11, 2023
Great article. If everyone followed Jack Bogle's excellent advice most of the financial services industry will disappear. Article Comments Invest Like a Legend: John Bogle's Blueprint for a Balanced Portfolio	1	Sep 11, 2023
Could you share how's GF Value of $34.22 calculated? PBF earned about the whole $34 in last 6 quarters, so the company basically worth 0 before 2022? Article Comments Unveiling PBF Energy (PBF)'s Value: Is It Really Priced Right? A Comprehensive Guide	0	Sep 8, 2023
those articles have no added value. better to look at the summary page of the stock Article Comments NovoCure Ltd (NVCR): A Deep Dive into Its Performance Potential	1	Sep 3, 2023
Great Feature! Question regarding the email alerts. Can I get email alerts only for the events that are relevant to my portfolio? Article Comments Introducing GuruFocus Financial Calendar	0	Sep 2, 2023
Another AI article. Shall look into context of what is happening with the trials of the company.... Article Comments NovoCure Ltd (NVCR): A Deep Dive into Its Performance Potential	0	Sep 2, 2023

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.

Discussion Board

What she bet most out of is Uipath (PATH) and Twillo ( TWLO).

Taking risks will blow my mind.

Appreciate the update and the clarification on yesterday's price drop

As a student, I've encountered my fair share of challenges in my studies. One of the most common issues I face is information overload. The vast amoun

If you look at the filing, Mr. Elmasri purchased the 500K shares for $0.00 so in that light not exactly a good thing.

Good summary of the book - quite difficult to practically implement as good quality companies / compounders are mostly always trading at high valuations and mostly slow growth low ROC companies at a discount

I suspect that something unique to SMCI is "breaking" your formula for GF value. Its number, and therefore the resulting conclusion, run contrary to s

"Align Technology Inc has witnessed a surge of 0.02% over a period" .... Please stop those absurd AI articles....

Heading is misleading, definitely NOT a comprehensive analysis.

This price of a share is very high. I know it does not matter - but buying 10 shares will take $40 K - a price of a nice car.

Good writing

Interesting that Gurufocus is now allowing articles for Cannabis companies. Previously I was told that these articles were not allowed.Also notably th

Thanks for highlighting Forward Air. The stock looks very interesting.

Berkshire Hatheway is terrible.

consider whether resmed has benefitted from Phillip&rsquo;s cpap recall and whether resmed will be negatively affected when phillips comes back into t

Great article. If everyone followed Jack Bogle's excellent advice most of the financial services industry will disappear.

Could you share how's GF Value of $34.22 calculated? PBF earned about the whole $34 in last 6 quarters, so the company basically worth 0 before 2022?

those articles have no added value. better to look at the summary page of the stock

Great Feature! Question regarding the email alerts. Can I get email alerts only for the events that are relevant to my portfolio?

Another AI article. Shall look into context of what is happening with the trials of the company....

consider whether resmed has benefitted from Phillip’s cpap recall and whether resmed will be negatively affected when phillips comes back into t